voxelotor

Global Blood’s Sickle Cell Drug Wins FDA Approval Ahead of Schedule
Xconomy
Mon, 11/25/19 - 10:14 pm
Global Blood Therapeutics
FDA
sickle cell disease
voxelotor
Oxbryta
Global Blood Therapeutics Goes Head to Head With Novartis On Sickle Cell
Motley Fool
Sun, 11/24/19 - 11:26 pm
Global Blood Therapeutics
voxelotor
Novartis
Adakveo
sickle cell disease
2 Biotechs With Approaching Drug Approvals
Motley Fool
Sun, 10/13/19 - 11:30 pm
drug approvals
drug launches
FDA
voxelotor
Global Blood Therapeutics
Immunomedics
sacituzumab govitecan
Why Global Blood Therapeutics Stock Jumped 10.9% Today
Motley Fool
Thu, 09/5/19 - 08:26 pm
Global Blood Therapeutics
FDA
voxelotor
sickle cell disease
GBT sickle cell trial hits endpoint ahead of NDA filing
Fierce Biotech
Fri, 06/14/19 - 10:06 am
Global Blood Therapeutics
sickle cell disease
FDA
voxelotor
The 20 Hottest Pipeline Drugs to Watch in 2019
BioSpace
Sun, 01/6/19 - 02:09 pm
VX-659 + tezacaftor + ivacaftor
semaglutide
JCAR017
ARGX-113
aducanumab
elafibranor
NKTR-214
DS-8201
GSK2857916
ozanimod
SGT-001
valoctocogene roxaparvovec
voxelotor
Upcoming events – Vertex awaits triplet data and GBT seeks approval for approval
EP Vantage
Sat, 11/17/18 - 12:49 pm
Vertex Pharma
cystic fibrosis
Symdeko
Kalydeco
Global Blood Therapeutics
voxelotor
sickle cell disease
GBT touts positive sickle cell trial, but shares yo-yo as investors mull data
Fierce Biotech
Wed, 06/27/18 - 12:01 pm
Global Blood Therapeutics
sickle cell disease
voxelotor
clinical trials